Induction and regulation of CD4+ T cell subsets

Area of Science:

• Immunology
• Vaccinology
• Parasitology

Background:

• CD4+ T cells differentiate into Th1 and Th2 subsets, influencing infectious and autoimmune disease outcomes.
• The balance between Th1 (secreting IL-2, IFN-gamma) and Th2 (secreting IL-4, IL-5, IL-10) cells is critical for immune response.
• Factors influencing Th1/Th2 cell induction and regulation are key to understanding immune modulation.

Purpose of the Study:

• To investigate the induction of Th1 cells and protective immunity using an oral vaccine delivery system.
• To evaluate the augmentation of vaccine efficacy through co-administration of specific cytokines.
• To explore the role of nitric oxide (NO) in modulating T cell subset responses.

Main Methods:

• Mice were infected with Leishmania, and an oral vaccine strain (BRD509) carrying parasite genes was administered.
• BRD509 was engineered to carry genes for IL-2, IFN-gamma, or tumor necrosis factor alpha to assess augmentation.
• Cloned mouse Th1 cells were used to study the inhibitory effect of nitric oxide (NO) on IFN-gamma production.

Main Results:

• Oral delivery of the vaccine preferentially induced Th1 cells and conferred protective immunity against Leishmania challenge.
• Vaccine efficacy was enhanced by co-administering BRD509 carrying genes for IL-2, IFN-gamma, or TNF-alpha.
• Nitric oxide (NO) was found to inhibit IFN-gamma production by Th1 cells.

Conclusions:

• Oral antigen and cytokine delivery can preferentially induce specific CD4+ T cell subsets.
• Modulating NO synthesis may offer a therapeutic strategy to sustain selective immune responses.
• This approach holds promise for developing effective immunotherapies against infectious diseases.